Disease & disorder
peripheral nervous system disorder
MONDO:0003620
A disease involving the peripheral nervous system.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
7 shownHeading Off Peripheral Neuropathy With ExerciseNCT00869804 · 2009-03-25
TERMINATEDSafety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive PatientsNCT00286377 · 2003-09-01
TERMINATEDNerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV DrugsNCT00017771 · 2001-06-01
COMPLETEDThe Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected PatientsNCT00000817 · 1994-11-01
COMPLETEDA Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory NeuropathyNCT00000842
COMPLETEDA Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV InfectionNCT00000793
COMPLETEDIntranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDSNCT00002083
COMPLETEDDrugs being studied
Research locations
BaltimoreMaryland, United States4New YorkNew York, United States4ChicagoIllinois, United States3Los AngelesCalifornia, United States3PhiladelphiaPennsylvania, United States3RochesterNew York, United States3SeattleWashington, United States3St LouisMissouri, United States3BirminghamAlabama, United States2BostonMassachusetts, United States2Chapel HillNorth Carolina, United States2ClevelandOhio, United States2
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.